Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 15/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 15/20 | 0.42 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29237218 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11LTB4RFFAR4 | |
| SCHEMBL30217175 | 0.87 | CYP4F2 (0.46) | CYP4F2CYP4A11LTB4RFFAR4 | |
| SCHEMBL29237203 | 0.87 | CYP4F2 (0.46) | CYP4F2CYP4A11LTB4RFFAR4 | |
| SCHEMBL30217034 | 0.81 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL29237206 | 0.81 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL30217228 | 0.80 | CYP4F2 (0.42) | CYP4F2CYP4A11LTB4RFFAR4 | |
| SCHEMBL31108596 | 0.79 | FFAR1 (0.37) | CYP4F2CYP4A11FFAR4 | |
| SCHEMBL30967899 | 0.77 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL31108635 | 0.76 | THRA (0.35) | CYP4F2CYP4A11FFAR4 | |
| SCHEMBL30217105 | 0.75 | CYP4F2 (0.34) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396179-A1 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-118201919-A | Indole compounds and methods of use | 健赞公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023034992-A1 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION (US) | 2023-03-09 | — | — | WO | disclosed |